Revenue Breakdown
Composition ()
No data
Revenue Streams
Cosmos Health Inc (COSM) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Wholesale , accounting for 91.8% of total sales, equivalent to $13.53M. Other significant revenue streams include Nutraceutical and pharmaceuticals and Pharma manufacturing. Understanding this composition is critical for investors evaluating how COSM navigates market cycles within the Pharmaceuticals industry.
Profitability & Margins
Evaluating the bottom line, Cosmos Health Inc maintains a gross margin of 13.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -10.63%, while the net margin is -31.28%. These profitability ratios, combined with a Return on Equity (ROE) of -63.82%, provide a clear picture of how effectively COSM converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, COSM competes directly with industry leaders such as ANEB and COCP. With a market capitalization of $14.69M, it holds a leading position in the sector. When comparing efficiency, COSM's gross margin of 13.00% stands against ANEB's N/A and COCP's N/A. Such benchmarking helps identify whether Cosmos Health Inc is trading at a premium or discount relative to its financial performance.
